MAPS Act aims to enhance federal coordination on essential medicines, assess supply chain risks, and map pharmaceutical supply chains.
The Mapping America’s Pharmaceutical Supply Act (MAPS Act) mandates the Department of Health and Human Services to maintain and update a list of essential medicines, focusing on those critical for responding to public health threats and at high risk of shortage. The bill requires a comprehensive risk assessment of the supply chains for these essential medicines, identifying vulnerabilities and potential national security risks. Additionally, it directs the mapping of pharmaceutical supply chains using data analytics, from the manufacturing of key starting materials to finished dosage forms.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.